Estimated incidence of COVID-19 illness and hospitalization — United States, February–September, 2020

@article{Reese2020EstimatedIO,
  title={Estimated incidence of COVID-19 illness and hospitalization — United States, February–September, 2020},
  author={Heather E. Reese and Angela Danielle Iuliano and Neha N Patel and Shikha Garg and Lindsay Kim and Benjamin J. Silk and Aron J Hall and Alicia M. Fry and Carrie Reed},
  journal={Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America},
  year={2020}
}
  • Heather E. Reese, A. Iuliano, +6 authors C. Reed
  • Published 25 November 2020
  • Medicine
  • Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Abstract Background In the United States, laboratory confirmed coronavirus disease 2019 (COVID-19) is nationally notifiable. However, reported case counts are recognized to be less than the true number of cases because detection and reporting are incomplete and can vary by disease severity, geography, and over time. Methods To estimate the cumulative incidence SARS-CoV-2 infections, symptomatic illnesses, and hospitalizations, we adapted a simple probabilistic multiplier model. Laboratory… 
View on PubMed
academic.oup.com
64 Citations
Highly Influential Citations
5
Background Citations
16
Methods Citations
3
Results Citations
3

Tables from this paper

64 Citations

Citation Type

Citation Type

Clinical Trends Among U.S. Adults Hospitalized with COVID-19, March-December 2020
TLDR
After initial improvement during April-October 2020, trends in interventions and outcomes worsened during November-December, corresponding with the 3rd peak of the U.S. pandemic.
Overall burden and characteristics of COVID-19 in the United States during 2020
TLDR
A data-driven model-inference approach is used to simulate the COVID-19 pandemic at county-scale in the United States during 2020 and estimate critical, time-varying epidemiological properties underpinning the dynamics of the virus.
Estimating COVID-19 Hospitalizations in the United States with surveillance data using a Bayesian Hierarchical model
TLDR
A method leveraging surveillance data to create a long-term solution to estimate monthly rates of hospitalizations for COVID-19 has potential to provide sustainable estimates for monitoring CO VID-19 burden, as well as a flexible framework leveraging Surveillance data.
Estimated SARS-CoV-2 Seroprevalence Among Persons Aged <18 Years — Mississippi, May–September 2020
TLDR
Serosurveys that include pediatric age groups can help provide evidence of cumulative disease incidence, estimate frequency of undiagnosed cases of SARS-CoV-2 among young persons, and guide prevention efforts.
Using test positivity and reported case rates to estimate state-level COVID-19 prevalence in the United States
TLDR
A single parameter semi-empirical model was developed, calibrated, and validated with prevalence predictions from two independent data-driven mathematical epidemiological models, each of which was separately validated using available cumulative infection estimates from recent state-wide serological testing in 6 states, and predictions are at least 10-fold more accurate than either test positivity or reported case rates alone.
The Missing Science: Epidemiological data gaps for COVID-19 policy in the United States
TLDR
Gaps remain in the epidemiological data required for an efficient and equitable public health policy response to COVID-19 and the existence of these gaps underscores the need for standardizing data collection and research priorities and protocols in the context of a rapidly emerging infectious disease epidemics.
Estimated SARS-CoV-2 Seroprevalence in Children and Adolescents in Mississippi, May Through September 2020
TLDR
Cumulative numbers of infections extrapolated from seroprevalence data, however, were estimated at 117,805, suggesting that cases in children and adolescents are much higher than what was reported to the Mississippi State Department of Health (9,044 cases during this period).
COVID-19 Severity: A New Approach to Quantifying Global Cases and Deaths
TLDR
An econometric strategy to estimate the true number of COVID-19 cases and deaths for roughly 60 countries from January 1 through November 3, 2020 using a 'structural' model based on the workhorse SIR epidemiological model extended to incorporate measurement error.
Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study
TLDR
The true extent of SARS-CoV-2 exposure in Mali is greater than previously reported and now approaches hypothetical herd immunity in urban areas and will be critical to implement effective mitigation strategies like vaccines.
Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Limited Clinical Disease in 3 Malian Communities: A Prospective Cohort Study
  • I. Sagara, J. Woodford, +15 authors P. Duffy
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2021
TLDR
The true extent of SARS-CoV-2 exposure in Mali is greater than previously reported and may now approach hypothetical 'herd immunity' in urban areas.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 39 REFERENCES
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020
TLDR
It is suggested that older adults have elevated rates of COVID-19-associated hospitalization and the majority of persons hospitalized with CO VID-19 have underlying medical conditions, which underscore the importance of preventive measures to protect older adults and persons with underlyingmedical conditions, as well as the general public.
Evidence for Limited Early Spread of COVID-19 Within the United States, January–February 2020
TLDR
Examination of four lines of evidence provides insight into the timing of introduction and early transmission of SARS-CoV-2, the virus that causes COVID-19, into the United States before the detection of these two cases, indicating that sustained, community transmission had begun before detection of the first two nontravel-related U.S. cases.
Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 1–July 25, 2020
TLDR
The cumulative rate of pediatric COVID-19-associated hospitalization remains low compared with that among adults, but weekly rates increased during the surveillance period, and one in three hospitalized children were admitted to the ICU, similar to the proportion among adults.
Epidemiology of COVID-19 Among Children in China
TLDR
The distribution of children’s COVID-19 cases varied with time and space, and most of the cases were concentrated in Hubei province and surrounding areas, providing strong evidence of human-to-human transmission.
A prospective cohort study in non-hospitalized household contacts with SARS-CoV-2 infection: symptom profiles and symptom change over time
  • A. Yousaf, L. Duca, +48 authors S. Nabity
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2020
TLDR
The symptom profiles from individuals with mild or asymptomatic SARS-CoV-2 infection are described and progression of symptoms over time is described to inform infection control, contact tracing, and community mitigation strategies.
Age-dependent effects in the transmission and control of COVID-19 epidemics
TLDR
It is found that interventions aimed at children might have a relatively small impact on reducing SARS-CoV-2 transmission, particularly if the transmissibility of subclinical infections is low.
COVID-19 antibody seroprevalence in Santa Clara County, California
TLDR
The estimated prevalence of SARS-CoV-2 antibodies in Santa Clara County implies that COVID-19 was likely more widespread than indicated by the number of cases in late March, 2020; at the time, low-burden contexts such asSanta Clara County were far from herd-immunity thresholds.
Risk Factors for Intensive Care Unit Admission and In-hospital Mortality among Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)
  • L. Kim, S. Garg, +23 authors G. Langley
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2020
TLDR
Aggressive implementation of prevention strategies, including social distancing and rigorous hand hygiene, may benefit the population as a whole, as well as those at highest risk for COVID-19-related complications.
Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: Systematic review and meta-analysis
TLDR
This work synthesizes all known cases of true asymptomatic coronavirus disease 2019 (COVID-19) and aims to synthesize all known avian influenza A viruses to help design mitigation measures against the pandemic.
COVID-19 Antibody Seroprevalence in Santa Clara County, California
TLDR
The population prevalence of SARS-CoV-2 antibodies in Santa Clara County implies that the infection is much more widespread than indicated by the number of confirmed cases.
...
1
2
3
4
...